Daclizumab (Yttrium-90-labeled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Daclizumab (Yttrium-90-labeled), covering 2017-05-25 to 2017-05-25. Get the full timeline:
Most recent: Clinical Trial Update: Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma [Phase 1, Phase 2]